EFFECT OF LIVER FIBROSIS STAGE AND DAA TREATMENT ON RISK OF CVD EVENTS IN ERCHIVES
Hepatitis C virus (HCV) infection is associated with a higher risk of cardiovascular disease (CVD) events. Treatment with directly acting antiviral (DAA) regimens has been shown to reduce this risk in most, but not all studies. How liver fibrosis stage affects risk of incidence CVD events after treatment with DAA regimens is unknown. We undertook…